Key statistics
On Tuesday, Gain Therapeutics Inc (GANX:NMQ) closed at 1.98, 122.47% above the 52 week low of 0.89 set on Aug 13, 2024.
52-week range
Short selling activityProvided by S&P Global Market Intelligence
Open | 2.16 |
---|---|
High | 2.16 |
Low | 1.87 |
Bid | 1.88 |
Offer | 2.10 |
Previous close | 2.14 |
Average volume | 441.26k |
---|---|
Shares outstanding | 25.54m |
Free float | 24.23m |
P/E (TTM) | -- |
Market cap | 54.52m USD |
EPS (TTM) | -1.33 USD |
Data delayed at least 15 minutes, as of Oct 08 2024 21:00 BST.
More ▼
Announcements
- Gain Therapeutics Presents Preclinical GT-02287 Data at Neuroscience 2024
- Gain Therapeutics to Participate at Upcoming Investor Conferences
- Gain Therapeutics Presents Phase 1 GT-02287 Data at International Congress of Parkinson’s Disease and Movement Disorders Demonstrating Increase in GCase Activity in Healthy Volunteers
- Gain Therapeutics To Host Virtual Webinar on Results From Phase 1 Study and Design of Upcoming Phase 1b Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease
- Gain Therapeutics to Present Preclinical GT-02287 Data in Parkinson’s Disease Models Including Two Late-Breakers at Neuroscience 2024
- Gain Therapeutics to Participate at H.C. Wainwright 26th Annual Global Investment Conference
- Gain Therapeutics Announces Positive Topline Results from the Phase 1 Clinical Trial of GT-02287, a Novel GCase-Targeting Small Molecule Therapy for Parkinson’s Disease
- Gain Therapeutics Reports Financial Results for Second Quarter 2024 and Provides Corporate Update
- Gain Therapeutics to Participate at BTIG Virtual Biotechnology Conference
- Gain Therapeutics to Hold a Business Update Conference Call on July 1, 2024
More ▼